Drug Interactions Corner

Back to articles

New Diagnostic Test Approved for CYP 2D6 and 2C19 Genotyping


Accurate patient-specific determination of the functional status of cytochrome (CYP) P450 enzymes can help clinicians predict and manage potential drug metabolism–related problems. A new FDA-approved test from Roche Diagnostics, the AmpliChip CYP450 Test, is able to provide just such information for CYP 2D6 and 2C19 enzymes.


Roche Diagnostics news release. January 12, 2005.

Lexi-Comp’s Pharmacogenomics Handbook. Humma LM, Ellingrod VL, Kolesar JM, eds. Hudson, Ohio: Lexi-Comp, Inc.; 2003.

Lexi-Comp’s Drug Interactions Handbook. Bachmann KA, Lewis JD, Fuller MA, Bonfiglio MF, eds. Hudson, Ohio: Lexi-Comp, Inc.; 2004.